UK small-cap RNS · 28 Jul 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Sort: Newest · Largest companies
-
14:50
-
12:15
-
12:08
Result of WRAP Retail Offer FundraiseBradda Head Lithium Ltd (AIM: BHLL), the North America-focused lithium development group, is pleased to confirm, further to the announcements made on 17 July 2026 and 21 July 2026, the result of its WRAP Retail Offer at the Issue Price of 2.25 pence per share.Dilutive fundraise +0.0% on the day
-
11:38
Petra Diamonds Ltd. PDL £9.2mQ4 and FY 2026 Operating & Business UpdateQ4 revenue fell 45% to US$38m on weaker prices and Finsch's suspension, and net debt rose to US$322m. Guidance stays suspended, so there is no formal warning against a target.Moved: Balance-sheet leverage: Second lien waivers secured on 5 June 2026 → Lender support secured; refinancing talks pending · Finsch financial review: Practitioners appointed; production suspended → Rescue ongoing; plan vote extended to August · Updated business plan execution: Guidance suspended; plan due end September 2026 → Section 189A ongoing; guidance suspended
-
07:37
Niox Group NIOX £279mTrading Update Trading updateFull-year trading is guided in line with consensus, but H1 revenue (£24.0m) and adjusted EBITDA (£8.3m) fell year on year as Research dropped, so delivery depends on a stronger H2.Moved: NIOX PRO device rollout: Launched; first sale December 2025; approvals pending → CE Mark and MHRA obtained; US/Japan pending · US direct sales transition: Direct sales team added alongside distributors → US field sales organisation fully deployed · NIOX MyNO home-use device: Early-stage development → Development underway
-
07:01
Nativo Resources NTVO £4.0mRetail Offer FundraiseNativo Resources PLC (LON: NTVO), the precious metals company with gold mining and processing interests in Peru, announces a retail offer via BookBuild ("Retail Offer") of new ordinary shares of 0.15 pence each ("Ordinary Shares") in the capital of the …
-
07:00
Final Results ResultsAudited FY to March 2026 confirms a pre-revenue investment year: revenue nil, operating loss £4.56m. Offsets are a first MoD revenue-bearing contract after year end, three proofs of concept and a full leadership team.Moved: MoD testing contract: Transparency Notice published; award not yet completed → Results cite revenue-bearing MoD contract after year end · Senior leadership build-out: CEO named; starts 30 March 2026 → CEO Andrew Roughan in post from 30 March 2026 (closed)
-
07:00
Bodycote BOY £1,541m2026 Interim Results ResultsCore organic growth of 9.6% and adjusted operating profit up 10.7% match expectations, with margins up and FY26 outlook unchanged after a weak FY25. Growth is expected to moderate in H2.Moved: Optimise programme and plant closures: On track; 21 of 31 sites exited → 27 of 31 closures complete; scope expansion explored · Aerospace and capacity build-out: Spectrum integration largely completed → Spectrum integrated; organic investments under way · £80m share buyback programme: Under way; £6.6m bought to 30 April → Under way; £12.6m spent in H1
-
07:00
Allergy Therapeutics AGY £285mAppointment of Executive Chairman Board changeChief Strategy Officer Helge Weiner-Trapness (ex-HSBC) becomes Executive Chairman, replacing long-serving Peter Jensen, to lead the Hong Kong dual-listing push. Combining executive and chair roles weakens board independence.Project milestones −0.4% on the dayMoved: Hong Kong dual listing: Still exploring; CFO awarded LTIP for workload → Still exploring; Executive Chairman appointed to lead
-
07:00
DP Poland DPP £58mPCA / PDMR Dealing Director dealingFollowing this transaction, the Malaccan Holdings Ltd Concert Party holds in aggregate 279,725,426 Ordinary Shares, representing 29.63% of the issued share capital.Insider conviction +0.0% on the day
-
07:00
Board Changes and Reconfirmation of FY26 OutlookCEO of eight years leaves by mutual agreement after the growth guidance cut and hydrogen delays; the company ties the change to its reduced scale and the slow hydrogen market.Moved: UK hydrogen new build contracts: HAR delayed; no FY26 revenue benefit → Hydrogen revenue removed from forecasts; upside only · FY25 results and FY26 earnings growth: growth dropped; guided flat on FY25 → Flat guidance reconfirmed; modest FY27 growth · new: Cost reduction and defence refocus – Board changes done; further savings targeted
-
07:00
Alien Metals Limited UFO £6.8mGreenTech Metals Quarterly Activities ReportPartner GreenTech's Munni Munni work (thicker PGE-copper-nickel zones, resource re-estimation, new drilling) is funded after a A$7.5m placement, advancing Alien's 30% free-carried stake without cost to Alien.Moved: Munni Munni exploration and resource update: Partner drilling done; re-estimation being prepared → Phase 1 results in; re-estimation and new drilling
-
07:00
Nativo Resources NTVO £4.0mPlacing and Subscription to Raise £640,000 FundraiseRetail Offer to Shareholders of up to £60,000 Through BookBuild
-
07:00
Publication of 2026 FY Annual Audited ReportThis is the audited FY to March 2026 report, not a profit warning. The loss rose on CAD$8.0m of Tunisia arbitration costs and CAD$6.8m of Tunisian impairments, while revenue was little changed.Moved: Tunisian authorities dispute and oil confiscation: Post-hearing briefs; award expected Q1 2027 → Post-hearing briefs; Tunisian assets impaired in audited accounts · Italian uranium exploration permits: FEI sale completed; Reveille admission due 7 July → Reveille created and listed (closed)
-
07:00
H1 2026 Trading Update Trading updateH1 sales are flat at constant currency and the Board says it is in line, with FY guidance of 3-5% revenue growth and a lower adjusted PBT loss unchanged. It confirms the plan set at the raise and adds no upgrade.Moved: US tariffs and net debt: Net debt repair funded, awaiting completion → Net debt cut to £6.2m; equity raise completed · Equity fundraise at 50p: Retail Offer closed, fully allocated; conditional → Completed in H1; £18.6m gross raised (closed) · Transformation plan: New CEO in place; targets reset, funding sought → Operational objectives in progress; leadership complete
-
07:00
Forterra FORT £322mSix months ended 30 June 2026H1 adjusted EBITDA of £27.0m (down 9.7%) with FY expectations unchanged and in line with consensus. This steadies the picture after May's warning of a wider range, but H2 demand is only assumed to match H1.Moved: 2026 guidance and Middle East costs: Wider range of 2026 outcomes; H2 weighted → FY expectations held at consensus; H2 uncertain · Capital allocation priorities: Priorities set; £20m buyback announced → Buyback under way; interim dividend cut
-
07:00
SSP Group SSPG £1,343mQ3 Trading Update Trading updateGuidance is only confirmed, not raised: FY26 EPS of 13.6-14.8p, FCF above £100m and ROCE progress stay 'on track', conditional on the Middle East environment staying unchanged.Moved: Multi-year strategic roadmap: 'Focus 26' progressing; Middle East risk → Q3: guidance held, buyback 76% done · Continental European Rail review: Review concluded; exits being implemented → Exit actions being implemented
-
07:00
Luceco LUCE £300mH1 2026 Trading Update Trading updateStrong H1 growth led by Energy Transition; FY26 Adjusted Operating Profit expected above £40m and FY27 expected ahead of consensus
-
07:00
H1-26 Trading Update Trading updateH1 revenue rose 45% to £3.2m and the 50-60% full-year guidance set in May is confirmed. Cash fell to £7.4m, and the guidance relies on the usual H2 weighting.Moved: Manufacturing disposal and outsourcing: Agreed on 16 April; cost saving restated → Completed in Q2 2026 (closed) · Sale of 49% Creo Medical SL stake: Non-binding agreement; completion targeted within three months → Completion expected during Q3-26 · Path to self-sustaining cashflows: Placing completed; admission pending → Placing and CLNs completed; cash £7.4m
-
07:00
AB Dynamics ABDP £182mTrading Update Trading updateRevenue guidance for continuing operations is cut to £90-95m on slower order conversion; margin is held at 20%, which only partly offsets the shortfall. The April message was a resilient H1 with profit in line.Upgrade / downgrade cycle below expectationsoutlook mixed, loweredfirst since Oct 2023 −29.5% on the dayMoved: VadoTech strategic review: Review announced; £16.8m exceptional charges booked → Review concluded: contract terminated, exit agreed (closed) · new: FY26 guidance reset – Revenue guidance cut; margin held at 20%
-
07:00
Kore Potash KP2 £186mReview of Operations - Quarter ended 30 June 2026Cash fell to c.US$7.5m from c.US$8.3m, financing is still unsigned and the ESIA is paused again. Positives: a second bidder joined the sale process and the 10% state stake holder is confirmed.Moved: Kola Potash financing and early works: Early works progressing; financing still unsigned → Financing unsigned; shaft FEED redesign continuing · Kola ESIA update and new DUP: ESIA resumed April 2026 after hiatus → ESIA suspended again from end May 2026 · Formal sale process: One bidder remains in due diligence → Two parties in process after new entrant
-
07:00
PCI-PAL PCIP £57mTrading Update Trading update· Annual Recurring Revenue ("ARR") increased 27% organically to £24.4m (FY25: £19.3m), or 29% on a constant currency ("CC") basis, representing an increase of £5.1m.